
GFR vs ESPR
$GFR vs $ESPR head to head: price, market cap, valuation, dividend, free float, relative volume and how actively each trades. The bigger value in the size rows is bolded. Tap either ticker for its live chart, full ownership breakdown and real-time alerts.
GFR vs ESPR: the quick read
- ·ESPR is the larger company by market cap ($819M vs $809M).
- ·GFR has been more active on our scanner (14 vs 0 alerts in 30 days).
- ·GFR has the smaller float (72.8M vs 253.1M), which tends to mean sharper, more volatile moves.
- ·These sit in different industries (UNKNOWN vs PHARMACEUTICAL PREPARATIONS), so they answer to different catalysts and a move in one says little about the other.
- ·Only one of them shows up on our scanner: GFR triggered 14 unusual-volume alerts in the last 30 days and the other triggered none.
- ·They are closely matched in size, within 1% of each other on market cap, which makes the rest of this table the interesting part.
- ·GFR is the one in play today, trading about 2.8x its normal volume, which is what puts a name on our scanner in the first place.
Objective differences only. Not investment advice.
Get the best catches in your inbox
Free daily email of the top plays and unusual-volume alerts our scanner flags. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Frequently asked questions
Everything you need to know comparing GFR and ESPR on TheDesperateTrader.
- Is GFR or ESPR the better stock?
- "Better" depends on your goal, and these two are not alike. ESPR is the larger company by market cap ($819M vs $809M). GFR has been more active on our scanner (14 vs 0 alerts in 30 days). GFR has the smaller float (72.8M vs 253.1M), which tends to mean sharper, more volatile moves. Those are the measured differences, not a recommendation, and nothing here is investment advice.
- What is the difference between GFR and ESPR?
- The differences that matter: they are not in the same business - GFR is unknown and ESPR is pharmaceutical preparations; they are similar in size ($809M vs $819M); GFR sits at 75% of its 52-week range against -76% for ESPR; our scanner flagged GFR 14 times in the last 30 days against 0 for ESPR. Everything above is measured from the latest completed session and SEC filings.
- Which of GFR and ESPR is more active right now?
- Neither is showing unusual volume on the latest session, so nothing here is being driven by a volume spike. Relative volume (RVOL) compares a stock's volume to its own recent average, so it reads the same way for a megacap and a microcap and is the quickest way to tell which of two similar names is actually in play.
- Is this comparison data live?
- Prices and % changes are anchored to the latest completed session and split-adjusted, so a reverse split never shows as a fake move. Float is estimated from SEC filings and refreshed as new filings publish.
Trading GFR or ESPR? Get real-time unusual-volume alerts the moment either one moves, free.
No card · 5 premium daysExplore the market
Free, live market tools. No account required to look.